Retraction
A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer
Paper Information
Record ID:
58986
Author(s):
Publication Date:
August 09, 2022
Retraction Date:
December 13, 2023
(1.9 year years ago)
Subjects:
Institutions:
- Department of Medical Science, University for Development, Accra, Ghana
- RD Lab, The Hospital Institute for Hebal Research, Toluca, MEX 50200, Mexico
- Research Institution of Clinical Biomedicine, Hospital University Medical Centre, Ulm 89000, Germany
- Industrial Research Group, International College of Science and Technology, Route de Lennik 800, CP 590, Brussels 1070, Belgium
- Clinical Analysis Lab, Center of Bio-Medicine, Hanoi, Vietnam
Countries:
Article Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations0
Post-Retraction3
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
QUALITY BY DESIGN APPROACH FOR DEVELOPMENT AND OPTIMIZATION OF CHITOSAN-BASED FLOATING MICROSPHERES FOR TOPOTECAN HCl
Prahlad Pragallapati, Revathi Naga Lakshmi Ponnuri, VENKATA RAMANA MURTHY KOLLAPALLI
International Journal of Applied Pharmaceutics
Open Access
Published: Nov 2023
2 citations
2 citations
36 days before retraction
Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy
Mehrab Pourmadadi, Amirhossein Ghaemi, Amin Shamsabadipour et al. (7 authors)
European Journal of Medicinal Chemistry
Published: Jun 2023
19 citations
19 citations
191 days before retraction
Retracted: A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
1 citation
1 citation
346 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025